Supernus Pharmaceuticals Gain (Loss) on Investment Securities (Quarterly) Analysis

Supernus Pharmaceuticals, Inc. (SUPN)

53.87 -0.40 (-0.74%) USD | NASDAQ | Mar 06, 16:00

53.92 +0.05 (+0.09%) After-Hours: 20:00

View Gain (Loss) on Investment Securities (Quarterly) for SUPN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Gain (Loss) on Investment Securities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Gain (Loss) on Investment Securities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Gain (Loss) on Investment Securities (Quarterly) Benchmarks

Start Trial

Biogen, Inc.	Upgrade
BridgeBio Pharma, Inc.	Upgrade
Corcept Therapeutics, Inc.	--
Catalyst Pharmaceuticals, Inc.	--
Cytokinetics, Inc.	Upgrade